Integra Lifesciences Holdings (IART) Total Debt Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.08% |
| Dec 31, 2025 | 12.83% |
| Sep 30, 2025 | 12.07% |
| Jun 30, 2025 | 2.58% |
| Mar 31, 2025 | 2.77% |
| Dec 31, 2024 | 5.96% |
| Sep 30, 2024 | -2.51% |
| Jun 30, 2024 | -1.21% |
| Mar 31, 2024 | -0.79% |
| Dec 31, 2023 | -7.71% |
| Sep 30, 2023 | -9.62% |
| Jun 30, 2023 | -12.28% |
| Mar 31, 2023 | -15.94% |
| Dec 31, 2022 | -15.63% |
| Sep 30, 2022 | -5.76% |
| Jun 30, 2022 | -0.22% |
| Mar 31, 2022 | -0.36% |
| Dec 31, 2021 | 5.50% |
| Sep 30, 2021 | 13.44% |
| Jun 30, 2021 | 12.47% |
| Mar 31, 2021 | 13.69% |
| Dec 31, 2020 | 14.28% |
| Sep 30, 2020 | 13.50% |
| Jun 30, 2020 | 18.45% |
| Mar 31, 2020 | 20.43% |
| Dec 31, 2019 | 24.43% |
| Sep 30, 2019 | 26.21% |
| Jun 30, 2019 | 24.25% |
| Mar 31, 2019 | 24.04% |
| Dec 31, 2018 | 45.84% |
| Sep 30, 2018 | 33.06% |
| Jun 30, 2018 | 34.08% |
| Mar 31, 2018 | 41.60% |
| Dec 31, 2017 | 41.16% |
| Sep 30, 2017 | 29.48% |
| Jun 30, 2017 | 22.28% |
| Mar 31, 2017 | 39.63% |
| Dec 31, 2016 | 29.92% |
| Sep 30, 2016 | 19.16% |
| Jun 30, 2016 | 27.29% |
| Mar 31, 2016 | 19.82% |
| Dec 31, 2015 | 14.87% |
| Sep 30, 2015 | 19.28% |
| Jun 30, 2015 | 14.71% |
| Dec 31, 2014 | 11.98% |